USPTO 2015–2025 USPTO PatentsView Foreign Corporation

TEL Hashomer Medical Research Infrastructure AND Services Ltd.

USPTO PatentsView assignee record - 109 granted patents across 35 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

109

Total patents granted

CPC technology areas

15.5

Avg claims per patent

+6%

5-year filing velocity

The verdict

TEL holds 109 US patents across 35 technology areas, rank #3,414 of 50,000 tracked assignees.

#3,414
of 50,000 US assignees by volume: Top 11%
by Innovation Score (51.5/100): 15.5
avg claims per patent: +6%
filing velocity, last 5 yrs

Portfolio overview

TEL Hashomer Medical Research Infrastructure AND Services Ltd. has been granted 109 US utility patents between 2015 and 2025, placing TEL Hashomer Medical Research Infrastructure AND Services Ltd. at rank #3,414 across all assignees tracked by PlainPatent. This portfolio spans 35 distinct Cooperative Patent Classification (CPC) subclasses, averaging 15.5 claims per patent with primary concentration in A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES). As a Foreign Corporation, TEL Hashomer Medical Research Infrastructure AND Services Ltd. is one of the more focused assignees in the PatentsView dataset. By volume, TEL sits between Skype (109 patents, rank #3,410) and Unilin BV (109 patents, rank #3,418) - the closest US assignees by grant volume. The composite Innovation Score of 51.5/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 56 grants, compared with 53 in the 2015–2019 window, a +6% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. TEL Hashomer Medical Research Infrastructure AND Services Ltd.'s 15.5 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 35 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark TEL Hashomer Medical Research Infrastructure AND Services Ltd. against peers pursuing similar technology classes.

Skype

109
Stepan

109
Salk Institute fo…

109
Storedot

109
The Stanley Works…

109
Toshiba Digital S…

109
Toshiba Kikai

109
Unilin BV

109
TEL Hashomer Medi… ◀

109

What this shows TEL holds 109 patents at rank #3,414, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near TEL

By rank, the assignees closest to #3,414 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in TEL's primary technology class.

TEL's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

51 Top 11% higher than 89% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

TEL Hashomer Medical Research Infrastructure AND Services Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	10	9.2%
2016	6	5.5%
2017	12	11.0%
2018	10	9.2%
2019	15	13.8%
2020	10	9.2%
2021	11	10.1%
2022	10	9.2%
2023	10	9.2%
2024	7	6.4%
2025	8	7.3%

Which technologies does TEL Hashomer Medical Research Infrastructure AND Services Ltd. patent most?

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 45

A61B - DIAGNOSIS; SURGERY; IDENTIFICATION 41

A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 39

C07K - PEPTIDES 22

C12N - MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA 18

G06T - IMAGE DATA PROCESSING OR GENERATION, IN GENERAL 17

A61F - FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRS 17

C12Q - MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES 12

G16H - HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA 9

G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 9

A61M - DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR 8

G06V - IMAGE OR VIDEO RECOGNITION OR UNDERSTANDING 6

G01R - MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES 6

Y02A - TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE 6

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY 6

Top 15 of 35 technology areas

Patent Moat Analysis

Portfolio Volume Moderate

Tech Breadth Multi-domain

Claim Depth Standard

Velocity Growing

Where it ranks

Overall rank by patents

#3,414

Across all tracked assignees

Innovation Score

51.5 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does TEL Hashomer Medical Research Infrastructure AND Services Ltd. hold?

TEL Hashomer Medical Research Infrastructure AND Services Ltd. holds 109 US granted patents filed between 2015 and 2025, spanning 35 technology areas.

What is TEL Hashomer Medical Research Infrastructure AND Services Ltd.'s Innovation Score?

TEL Hashomer Medical Research Infrastructure AND Services Ltd. has an Innovation Score of 51.5 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does TEL Hashomer Medical Research Infrastructure AND Services Ltd. focus on?

TEL Hashomer Medical Research Infrastructure AND Services Ltd.'s top technology area is A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES) with 45 patents. The company has filed patents in 35 CPC subclasses total.

Is TEL Hashomer Medical Research Infrastructure AND Services Ltd.'s patent filing rate increasing or decreasing?

TEL Hashomer Medical Research Infrastructure AND Services Ltd.'s recent filing velocity is +6% compared to the prior five-year period. The company is maintaining or growing its patent output.

What does claim depth mean for TEL Hashomer Medical Research Infrastructure AND Services Ltd.'s patents?

TEL Hashomer Medical Research Infrastructure AND Services Ltd.'s patents average 15.5 claims each. This falls within the standard range, providing solid legal coverage.

How is the TEL Hashomer Medical Research Infrastructure AND Services Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

TEL's 109 grants land it in the top 11% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - TEL ranks #3,414 of 50,000. Top 50 holders
Most of this portfolio concentrates in A61K - see who else leads that technology area. A61K leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.